Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synthesis, structural characterization, DFT calculations, molecular docking, and molecular dynamics simulations of a novel ferrocene derivative to unravel its potential antitumor activity
Mohamed M. Hammoud, Muhammad Khattab, Marwa Abdel‐Motaal, et al.
Journal of Biomolecular Structure and Dynamics (2022), pp. 1-18
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Synthesis of New Organoselenium-Based Succinanilic and Maleanilic Derivatives and In Silico Studies as Possible SARS-CoV-2 Main Protease Inhibitors
Saad Shaaban, Yasair S. Al-Faiyz, Ghayah M. Alsulaim, et al.
Inorganics (2023) Vol. 11, Iss. 8, pp. 321-321
Open Access | Times Cited: 50
Ligand-Based Design on the Dog-Bone-Shaped BIBR1532 Pharmacophoric Features and Synthesis of Novel Analogues as Promising Telomerase Inhibitors with In Vitro and In Vivo Evaluations
Ahmed A. Al‐Karmalawy, Mohamed S. Nafie, Moataz A. Shaldam, et al.
Journal of Medicinal Chemistry (2022) Vol. 66, Iss. 1, pp. 777-792
Closed Access | Times Cited: 41
In vitroand computational investigations of novel synthetic carboxamide-linked pyridopyrrolopyrimidines with potent activity as SARS-CoV-2-MProinhibitors
Ateyatallah Aljuhani, Hany E. A. Ahmed, Saleh Ihmaid, et al.
RSC Advances (2022) Vol. 12, Iss. 41, pp. 26895-26907
Open Access | Times Cited: 39
Anticoagulants as Potential SARS-CoV-2 Mpro Inhibitors for COVID-19 Patients: In Vitro, Molecular Docking, Molecular Dynamics, DFT, and SAR Studies
Ayman Abo Elmaaty, Wagdy M. Eldehna, Muhammad Khattab, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12235-12235
Open Access | Times Cited: 39
Design and synthesis of novel benzoazoninone derivatives as potential CBSIs and apoptotic inducers: In Vitro, in Vivo, molecular docking, molecular dynamics, and SAR studies
Mohamed M. Hammouda, Ayman Abo Elmaaty, Mohamed S. Nafie, et al.
Bioorganic Chemistry (2022) Vol. 127, pp. 105995-105995
Closed Access | Times Cited: 37
Phenylpyrazolone-1,2,3-triazole Hybrids as Potent Antiviral Agents with Promising SARS-CoV-2 Main Protease Inhibition Potential
Arafa Musa, Hamada S. Abulkhair, Ateyatallah Aljuhani, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 463-463
Open Access | Times Cited: 33
Novel 4-thiophenyl-pyrazole, pyridine, and pyrimidine derivatives as potential antitumor candidates targeting both EGFR and VEGFR-2; design, synthesis, biological evaluations, andin silicostudies
Samia M. Al-Muntaser, Ahmed A. Al‐Karmalawy, Abeer M. El‐Naggar, et al.
RSC Advances (2023) Vol. 13, Iss. 18, pp. 12184-12203
Open Access | Times Cited: 25
Metformin ameliorates doxorubicin-induced cardiotoxicity targeting HMGB1/TLR4/NLRP3 signaling pathway in mice
Amany A. Alzokaky, Ahmed A. Al‐Karmalawy, Mohamed A. Saleh, et al.
Life Sciences (2023) Vol. 316, pp. 121390-121390
Closed Access | Times Cited: 21
Synthesis of 1-Piperoylpiperidine Investigated Through Spectroscopy, Quantum Computation, Pharmaceutical Activity, Docking and MD Simulation Against Breast Cancer
Kaliraj Chandran, Azar Zochedh, S. Asath Bahadur, et al.
Polycyclic aromatic compounds (2023) Vol. 44, Iss. 6, pp. 3825-3859
Closed Access | Times Cited: 21
Design, synthesis, and mechanistic insight of novel imidazolones as potential EGFR inhibitors and apoptosis inducers
Fatma G. Abdulrahman, Hamada S. Abulkhair, Hoda S. El Saeed, et al.
Bioorganic Chemistry (2024) Vol. 144, pp. 107105-107105
Closed Access | Times Cited: 6
Design and synthesis of new 1,2,3-triazole derivatives as VEGFR-2/telomerase downregulatory candidates endowed with apoptotic potential for cancer treatment
Ahmed A. Al‐Karmalawy, Mohamed A. Zeidan, Ayman Abo Elmaaty, et al.
Bioorganic Chemistry (2025) Vol. 156, pp. 108159-108159
Closed Access
Ligand-based design, synthesis, computational insights, andin vitrostudies of novelN-(5-Nitrothiazol-2-yl)-carboxamido derivatives as potent inhibitors of SARS-CoV-2 main protease
Mohamed Elagawany, Ayman Abo Elmaaty, Ahmed Mostafa, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 2112-2132
Open Access | Times Cited: 34
The effect of novel synthetic semicarbazone- and thiosemicarbazone-linked 1,2,3-triazoles on the apoptotic markers, VEGFR-2, and cell cycle of myeloid leukemia
Esraa M. Othman, Eman A. Fayed, Ebtehal M. Husseiny, et al.
Bioorganic Chemistry (2022) Vol. 127, pp. 105968-105968
Closed Access | Times Cited: 30
Investigating the possible mechanisms of pirfenidone to be targeted as a promising anti-inflammatory, anti-fibrotic, anti-oxidant, anti-apoptotic, anti-tumor, and/or anti-SARS-CoV-2
Samar A. Antar, Mohamed A. Saleh, Ahmed A. Al‐Karmalawy
Life Sciences (2022) Vol. 309, pp. 121048-121048
Open Access | Times Cited: 30
Biological evaluation, docking studies, and in silico ADME prediction of some pyrimidine and pyridine derivatives as potential EGFR WT and EGFR T790M inhibitors
Tarfah Al‐Warhi, Ahmed A. Al‐Karmalawy, Ayman Abo Elmaaty, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 38, Iss. 1, pp. 176-191
Open Access | Times Cited: 26
The anticancer and EGFR-TK/CDK-9 dual inhibitory potentials of new synthetic pyranopyrazole and pyrazolone derivatives: X-ray crystallography, in vitro , and in silico mechanistic investigations
Arafa Musa, Saleh Ihmaid, David L. Hughes, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 21, pp. 12411-12425
Open Access | Times Cited: 17
Exploring the cytotoxic effect and CDK-9 inhibition potential of novel sulfaguanidine-based azopyrazolidine-3,5-diones and 3,5-diaminoazopyrazoles
Ebtehal M. Husseiny, Hamada S. Abulkhair, Nehad M. El‐Dydamony, et al.
Bioorganic Chemistry (2023) Vol. 133, pp. 106397-106397
Closed Access | Times Cited: 16
Design and synthesis of novel rigid dibenzo[ b,f ]azepines through ring closure technique as promising anticancer candidates against leukaemia and acting as selective topoisomerase II inhibitors and DNA intercalators
Mohammed Farrag El‐Behairy, Walaa Hamada Abd‐Allah, Mohamed M. Khalifa, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 15
A novel class of phenylpyrazolone-sulphonamides rigid synthetic anticancer molecules selectively inhibit the isoform IX of carbonic anhydrases guided by molecular docking and orbital analyses
Maan T. Khayat, Hany E. A. Ahmed, Abdelsattar M. Omar, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 24, pp. 15243-15261
Closed Access | Times Cited: 14
Lead Optimization of BIBR1591 To Improve Its Telomerase Inhibitory Activity: Design and Synthesis of Novel Four Chemical Series with In Silico, In Vitro, and In Vivo Preclinical Assessments
Ahmed A. Al‐Karmalawy, Mai H. A. Mousa, Marwa Sharaky, et al.
Journal of Medicinal Chemistry (2023) Vol. 67, Iss. 1, pp. 492-512
Closed Access | Times Cited: 13
Rationale design of novel substituted 1,3,5-triazine candidates as dual IDH1(R132H)/ IDH2(R140Q) inhibitors with high selectivity against acute myeloid leukemia: In vitro and in vivo preclinical investigations
Haytham O. Tawfik, Mai H. A. Mousa, Mohamed Y. Zaky, et al.
Bioorganic Chemistry (2024) Vol. 149, pp. 107483-107483
Closed Access | Times Cited: 3
Exploring the dual effect of novel 1,4-diarylpyranopyrazoles as antiviral and anti-inflammatory for the management of SARS-CoV-2 and associated inflammatory symptoms
Azizah M. Malebari, Hany E. A. Ahmed, Saleh Ihmaid, et al.
Bioorganic Chemistry (2022) Vol. 130, pp. 106255-106255
Open Access | Times Cited: 18
Design and synthesis of novel quinazolinone–chalcone hybrids as potential apoptotic candidates targeting caspase-3 and PARP-1:in vitro, molecular docking, and SAR studies
Eman A. Madbouly, El‐Sayed M. Lashine, Ahmed A. Al‐Karmalawy, et al.
New Journal of Chemistry (2022) Vol. 46, Iss. 46, pp. 22013-22029
Closed Access | Times Cited: 17
Novel benzochromenes: design, synthesis, cytotoxicity, molecular docking and mechanistic investigations
Fatma G. Abdulrahman, Hamada S. Abulkhair, Riham A. Zidan, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 2, pp. 105-123
Closed Access | Times Cited: 2
In vivo evaluation of novel synthetic pyrazolones as CDK9 inhibitors with enhanced pharmacokinetic properties
Ebtehal M. Husseiny, Hamada S. Abulkhair, Samiha A. El‐Sebaey, et al.
Future Medicinal Chemistry (2024), pp. 1-19
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top